We are so pleased and excited to share the news with our epilepsy community that Laura Krasovec from NeuroPace, will be our guest speaker January 15, 2026.

Laura will speak to us about the, Responsive Neurostimulation System, or RNS, capabilities for people with drug resistant epilepsy.

Join us in person or via Zoom.

LOCATION:

Stanford Health
3rd Fl, Board Rm 2
5575 W. Las Positas Pleasanton, CA

3rd Thursday of the Month at 5pm

Personal Bio:

Laura has an extensive background in biomedical engineering with 8 years of experience in neurotechnology. She works at NeuroPace to support all of the patients and physicians in Northern California – both prior to surgery to help identify appropriate candidates, during surgery to assist the surgeon and speak with the patients about the device, and after to help optimize treatment with the device. Her goal is to increase access to the RNS therapy for patients and physicians and help with care throughout the treatment process.

Company Bio:

The RNS® System is the only FDA-approved epilepsy device that delivers personalized treatment by responding to abnormal brain activity and provides EEG data that can help improve patient care.

The RNS System can help patients achieve significant seizure reduction and quality of life improvements resulting in life-changing outcomes.

The RNS System responds to a patient’s unique seizure fingerprint— so patients get the personalized treatment they need, when they need it.

Data from the RNS System provides unprecedented visibility into seizure trends and triggers that can help physicians optimize patient treatment plans.